Clinical Trials Directory

Trials / Unknown

UnknownNCT02135952

Metronidazole and Amoxicillin for the Treatment of Type 2 Diabetic Subjects With Periodontitis

Metronidazole and Amoxicillin as Adjuncts to Scaling and Root Planing for the Treatment of Type 2 Diabetic Subjects With Periodontitis: a Randomized Placebo-controlled Clinical Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
58 (actual)
Sponsor
University of Guarulhos · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Not accepted

Summary

Diabetes mellitus (DM) is a widely prevalent disease associated with several major systemic and oral complications, such as periodontitis. The use of adjunctive local and/or systemic antimicrobials has been proposed to improve the clinical and glycemic outcomes of the scaling and root planing (SRP) in diabetic subjects. The combination of metronidazole (MTZ) and amoxicillin (AMX) has been largely recognized as an effective therapy for improving the clinical and microbiological outcomes of SRP in the treatment of with chronic periodontitis (ChP). However, no previous clinical trials to date have evaluated the effects of this antibiotic combination in the treatment of diabetic subjects with periodontitis. Therefore, the aim of this randomized clinical trial (RCT) will be to evaluate the clinical and microbiological effects of the use of MTZ+AMX as adjuncts to SRP for the treatment of type 2 diabetic subjects with generalized ChP.

Conditions

Interventions

TypeNameDescription
PROCEDURESRPSRP in four to six appointments lasting approximately 1 h each, using manual curettes and ultrasonic device under local anesthesia.
OTHERPlaceboAdministration of placebo for 14 days started immediately after the first session of SRP.
DRUGMTZ+AMXAdministration of antibiotics (metronidazole and amoxicillin) for 14 days started immediately after the first session of SRP.

Timeline

Start date
2011-09-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2014-05-12
Last updated
2014-05-12

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02135952. Inclusion in this directory is not an endorsement.